3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
15
Recurrence
8
Hodgkin Disease
6
Breast Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
5
Sezary Syndrome
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Mycosis Fungoides
4
Leukemia, Myeloid, Acute
4
Leukemia
4
Waldenstrom Macroglobulinemia
3
Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Prostatic Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Immunoblastic Lymphadenopathy
2
Glioma
2
Diffuse Intrinsic Pontine Glioma
2
Carcinoma, Renal Cell
2
Interventions
Sunitinib
19
Everolimus
17
Bevacizumab
13
aldesleukin
11
Sorafenib
11
Interleukin-2
10
Cyclophosphamide
10
Axitinib
10
Nivolumab
9
fludarabine phosphate
7
fludarabine
7
pembrolizumab
5
Gemcitabine
5
temsirolimus
4
pazopanib
4
Ipilimumab
4
peginterferon alfa-2b
3
durvalumab
3
cabozantinib
3
Radiosurgery
3
Interferon-alpha
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Filgrastim
3
Erlotinib Hydrochloride
3
Cryosurgery
3
vandetanib
2
spartalizumab
2
perflutren
2
ixabepilone
2
chiron
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Kidney Neoplasms
×
Panobinostat
×
Clear all
No trials found.